Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04963803 · ClinicalTrials.gov registry record · NA
Improving Aphasia Using Electrical Brain Stimulation
A NA study, sponsored by Syracuse University.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT04963803: Completed NA study, sponsored by Syracuse University.
NCT04963803 is a NA study that has completed, run by Syracuse University. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04963803, a NA study, has completed, sponsored by Syracuse University.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
Language and communication are essential for almost every aspect of human life, but for people who have aphasia, a language processing disorder that can occur after stroke or brain injury, even simple conversations can become a formidable challenge. Speech and language therapy can help people recover their language ability, but often requires months or even years of therapy before a person is able to overcome these challenges. This research will investigate non-invasive brain stimulation as a way to enhance the effects of speech and language therapy, which may ultimately lead to better and faster recovery from stroke and aphasia. The investigators hypothesize that participants with aphasia who receive speech and language therapy paired with active electrical brain stimulation will improve significantly more on a language comprehension task than those who receive speech and language therapy paired with sham stimulation.
Primary Outcome
Measurement of auditory comprehension for untrained sentence-level stimuli. Participants listen to a sentence and are asked to answer comprehension questions about the sentence they heard. Results are reported as the percentage of correct responses out of the total number of items administered. Higher percentages indicate better performance and less auditory comprehension impairment.
Interventions
- DEVICE Sham transcranial direct current stimulation (tDCS)
- DEVICE Active transcranial direct current stimulation (tDCS)
- BEHAVIORAL Language Specific Attention Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2021-07-12 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the finished NCT04963803 record still lists
NCT04963803 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Sham transcranial direct current stimulation (tDCS) is the first listed.
NCT04963803 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04963803 about?
NCT04963803 is a clinical study titled "Improving Aphasia Using Electrical Brain Stimulation". Language and communication are essential for almost every aspect of human life, but for people who have aphasia, a language processing disorder that can occur after stroke or brain injury, even simple conversations can become a formidable challenge. Speech and language therapy can help people recove...
What is the current status of trial NCT04963803?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2021-07-12. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT04963803?
The interventions under investigation include: Sham transcranial direct current stimulation (tDCS) (DEVICE), Active transcranial direct current stimulation (tDCS) (DEVICE), Language Specific Attention Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04963803?
This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04963803's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI